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Purpose: This study aimed to determine the frequency rates of human immunodeficiency virus (HIV), 
hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis among blood donors. 
Methods: Physically fit persons aged 18 – 48 years who came for blood donation at the blood bank unit 
of the military hospital in Hodeidah, Yemen  (MHH) from November 2008 to October 2010 were 
screened using standard diagnostic (SD) reagents. Based on the results, donors with clinical anemia 
and with history of jaundice were excluded.  
Results: A total of 1,483 male donors (96 % semi-voluntary and 4 % replacement donors) with a mean 
age of 24.3 years were enrolled in this study. The frequencies of HBV, HCV, HIV and syphilis in the 
samples were 2.35, 0.79, 0.14, and 0.34 %, respectively. Compared with the first year, the decrease in 
HBV and HCV positive cases and the increase in HIV and syphilis positive cases in the second year 
were not statistically significant (p = 0.91, p = 0.74, p = 0.72, and p = 0.92, respectively).  
Conclusion: While the frequency rate of transfusion-transmitted infections (TTIs) is low, it remains a 
major problem in blood transfusion. Proper protocol should be applied in selecting and screening donors 
to safeguard the health of people receiving blood transfusions. 
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Transfusion-transmitted infections (TTIs) 
acquired through the therapeutic blood 
transfusion process is a major universal 
health problem in transfusion medicine that 
should be addressed. Therefore, minimizing 
this complication should be encouraged [1]. 
 
Hepatitis B virus (HBV), hepatitis C virus 
(HCV), human immunodeficiency virus (HIV) 
and syphilis are the most serious infections 
transmitted during blood transfusion. 
Complications associated with TTI include 
long-term morbidity and mortality, delayed 
viraemia, and hidden states make TTIs an 
important issue in transfusion medicine [2]. 
HBV and HCV are major causes of chronic 
liver diseases worldwide, especially cirrhosis 
and hepatocellular carcinoma [3]. They are 
transmitted through the blood, vertically from 
mothers to offspring and horizontally through 
blood products and body secretions [4]. On 
the other hand, HIV and syphilis could be 
transmitted horizontally through sexual 
intercourse and organ transplantation, and 
vertically from mother to children [5]. 
 
The trend rates of these infections among 
blood donors should be assessed and 
evaluated, to ensure the safety of blood 
supply and the efficiency of donor screening 
[6]. This information could also reflect the 
occurrence of these diseases in the 
community. Consequently, it will help in 
estimating the dangers associated with blood 
transfusion, as well as in modifying donor-
screening strategies to reduce the 
transmission of infections [7]. 
 
Scott et al reported that the carrier rate of an 
HBV surface antigen (HBsAg) among the 
general population in Yemen was 12.7 %, 
while the prevalence of HCV was 2.6 % [8]. 
Al-Harbi and Al-Robasi reported that the 
prevalence of HBsAg in blood donors was 9 
% [9]. Blood safety in transfusion medicine is 
important, particularly in Yemen, due to the 
lack of blood transfusion services and 
financial support, as well as failure to 
implement policies. These concerns are 
aggravated by inappropriate training of 
employees in transfusion centers, outdated 
communication facilities, the absence of a 
systematic approach in implementing blood 
transfusion services, and the dearth of 
research in Hodeidah City on transfusion 
medicine. These are possible reasons for the 
increased prevalence of TTIs. This study 
aims to address these concerns by 
determining the frequency rates and trends of 
serological markers of HBV, HCV, HIV, and 
syphilis in the blood donors at the blood bank 





This study was conducted from November 1, 
2008 to October 30, 2010 at the blood bank 
unit of the military hospital in Hodeidah 
(MHH), Yemen. The subjects were male 
blood donors at a blood bank unit at MHH. 
Blood donation in Yemen is semi-voluntary in 
that friends and relatives of patients donate 
blood. Thus physical examination and full 
history were performed and taken on all 
volunteer blood donors to review their 
eligibility for donation. This study was 
approved by the Ethics and Research 
Committee of the Ministry of Public Health 




Physically fit people aged 18 – 48 years who 




Potential donors were excluded if they were 
below 18 years old, weighed less than 50 kg, 
had anemia and a history of jaundice within 
the past six months, engaged in high-risk 
behavior (i.e., unsafe intercourse, drug use, 
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Over two-year period, 1,483 blood donors 
were reviewed in the blood bank unit of MHH. 
Blood samples (8 ml each) were tested for 
anti-HCV, HBsAg, HIV, and syphilis. 
Standard diagnostic (SD) reagents for 
immunochromatographic rapid test were 
used to detect viral markers. Repeatedly 
reactive specimens in two separate tests 




Data were analyzed using SPSS version 16. 
Chi-Square test was used to compare 
infection rates in two consecutive years and 





A total of 1483 male donors (96 % semi-
voluntary and 4 % replacement donors) with 
a mean age of 24.3 years were involved in 
this study. Thirty five of 1483 (2.40 %) were 
positive for HBsAg and 12 (0.79 %) positive 
for anti-HCV. Five (0.34 %) and 2 (0.14 %) 
tested positive for syphilis and HIV, 
respectively.  
 
During the first year, 22 (2.40 %) were 
positive for HBV and 8 (0.87 %) for HCV, 
while in the second year 13 (2.30 %) and 4 
(0.71 %) were positive for HBV and HCV, 
respectively. The positivity of syphilis and 
HIV, in the first year was 3 (0.33 %) and 1 
(0.1 %) respectively. In the second year, 2 
(0.35 %) were positive for syphilis and 1 (0.18 
%) was positive for HIV.  One donor showed 
double positivity for syphilis and HIV.  
 
The overall frequencies of HBsAg, HCV, HIV, 
and syphilis were 2.35, 0.79, 0.14, and 0.34 
%, respectively. The frequency rates of HBV 
and HCV declined slightly in the second year 
(2.30 %, 0.71 %) compared with the first year 
(2.40 %, 0.87 %). However, syphilis and HIV 
rates increased slightly in the second year 
(0.35 % and 0.18 %) compared with the first 
year (0.33 %, 0.10 %). However, as Table 1 
shows, these changes in frequency rates 




In general, the diagnosis of HBV, HCV, HIV 
and syphilis is based on the presence of the 
corresponding antigens or antibodies in blood 
serum [7,15]. This study used serological 
methods to evaluate the seroprevalence of 
HBV, HCV, HIV, and syphilis infections 
among blood donors in the blood bank unit of 
MHH in 2009 and 2010. 
 
Table 1: Frequency rates of HBV, HCV, HIV, and syphilis among blood donors for two years at MHH, 
Yemen 
 
















919 22 (2.40) 1.03 (0.54 – 1.97) HBsAg 






919 8 (0.87) 0.81 (0.24 – 2.66) Anti-HCV 










2 (0.14)  1.63 (0.10 – 26.2) 0.72 






5 (0.34) 1.08 (0.18 – 6.45) 0.92 
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HBV frequency in this study was different 
from that reported for Yemen by Alrobasi et al 
and Scott et al, which were 9  and 12.7 %, 
respectively [8,9]. Similar frequency rates of 
HBV have been reported, such as those in 
Nahavand, Iran (2.3 %) [10] and Rawalpindi, 
Pakistan (2.45 %) [11], while a significantly 
lower rate of HBV has been reported in 
Mexico (0.16 %) [12]. HCV in the blood 
donors in the study was 0.79 %, which is 
lower than the 2.6 % overall rate in Yemen 
[8], 5.1 % in India, and 6 % in Africa [13]. 
However, it is considerably higher than the 
0.4 % in Saudi Arabia [3]. The frequency 
rates of HBV and HCV decreased from 2.40 
% to 2.30 % and from 0.87 % to 0.71 %, 
respectively. However, this decrease was not 
statistically significant (p = 0.91, p = 0.74, 
respectively). 
 
HIV-positive cases in this study accounted for 
0.14 % of the sample, which is lower than the 
0.80 % in East Delhi, India [11] and 0.96 % in 
Nigeria [1]. However, it is higher than the 0 % 
in Islamabad and Bahawalpur in Pakistan 
[11]. Positive cases of syphilis accounted for 
0.34 % of the sample, which is lower than the 
0.75 % in Pakistan [11], but higher than the 
0.1 % in Port Harcourt, South-South, Nigeria 
[14]. On the other hand, syphilis and HIV 
showed a slight increase in frequency rates in 
the second year (0.35 and 0.18 %) when 
compared to the frequency rates of the first 
year (0.32 and 0.10 %). However, this 
increase was not statistically significant (p = 
0.92 % and p = 72 %, respectively).  
 
The differences in frequency rates across 
geographic regions may be caused by 
differences in geography, socio-economic 
status, and subject selection in the studies 
cited.  
 
Based on the results as well as the limitations 
of the current study, namely, insufficiency of 
sample size and lack of specificity of some 
diagnostic tests, we recognize that proper 
strategies to detect TTIs early among blood 
donors in Yemen need to be implemented. 
The screening process should include anti-
HBc testing to detect occult HBV carriers as 
well as donors with HBV escape mutants. 
This will facilitate adoption of preventive 
procedures, which can safeguard the health 
of individuals as well as workers in hospitals 
and medical centers. Highly specific and 
sensitive systems, and improved worker 
efficiency may help manage the hazards 




Based on the findings of the current study 
and other studies which have been done in 
Yemen, the results of these studies are 
different. Furthermore, there are no specific 
strategies for the screening of blood donors 
that is followed in the blood bank centers in 
Yemen. Therefore, the current study will help 
to establish an accurate framework for the 
screening process of blood donors.   
  
The blood donors in Yemen can be classified 
as having low-risk behavior. The data reflects 
lower rate of positivity for TTIs compared with 
the prevalence of these infections in other 
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